Biohaven Ltd. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Biohaven Ltd. (BHVN) holds an ST Score of 35.3 out of 100 (C-), with its strongest factor being Valuation (B) and its weakest Profitability (F). Analysts rate BHVN Buy across 25 ratings with a $20.00 average price target (+0.4% vs the current $14.22).
- Strongest
- ValuationB
- Weakest
- ProfitabilityF
All factor grades
- ValuationB
- MomentumC+
- ForecastC+
- GrowthC
- Financial StrengthD+
- ProfitabilityF
- Piotroski2/9
Contact
BHVN stock: frequently asked questions
What is BHVN's ST Score?
Biohaven Ltd. (BHVN) has an ST Score of 35.3 out of 100, an overall grade of C-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BHVN a buy, sell, or hold?
Wall Street's consensus rating on BHVN is Buy based on 25 analyst ratings. Our own ST Score grades it C- (35.3/100). This is data, not investment advice — always do your own research.
What is BHVN's valuation grade?
Biohaven Ltd. (BHVN) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BHVN's growth grade?
Biohaven Ltd. (BHVN) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BHVN's profitability grade?
Biohaven Ltd. (BHVN) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BHVN's financial strength grade?
Biohaven Ltd. (BHVN) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BHVN?
The average analyst price target for Biohaven Ltd. (BHVN) is $20.00 from 25 analysts, which is +0.4% versus the recent price of $14.22.
What is BHVN's Piotroski score?
Biohaven Ltd. (BHVN) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.